SLS Katherine Bach Kalin buys $101K worth of shares
Nov 22, 2025, 5:36 AM
0.00%
What does SLS do
SELLAS Life Sciences Group, a clinical stage biopharmaceutical company based in New York, develops immunotherapeutics for cancer, including galinpepimut-S and SLS009. The company went public in 2008 and employs 16 staff.
Katherine Bach Kalin bought 63,400 shares of SLS on 19 November at $1.59 per share, worth a total of $101K. They now own 104,400 SLS shares, or a 155% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.